Euratom
10/09/25 10:17
Ha respondido al tema
Novo Nordisk (NOV)
https://www.investegate.co.uk/announcement/gnw/novo-nordisk-a-s-class-b--0qiu/novo-nordisk-to-streamline-operations-and-rei-/9097599 Novo Nordisk announced a company-wide transformation to streamline operations and focus on growth opportunities within diabetes and obesity, expecting to reduce approximately 9,000 roles globally. This restructuring is projected to yield annualised savings of DKK 8 billion by the end of 2026, which will be reinvested into growth initiatives. The company anticipates incurring DKK 8 billion in one-off restructuring costs, primarily in the third quarter of 2025, leading to a revised full-year 2025 operating profit growth outlook of 4-10% at CER, compared to the previous expectation of 10-16%. Depreciation, amortisation and impairment losses are now expected to be around DKK 21 billion.